Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques

Safety of Conventional Systemic Agents and Biologic Agents in the Treatment of Psoriasis

(2015) Robert Bissonnette et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life

(2013) F Sampogna et al.   ACTA DERMATO-VENEREOLOGICA

Parenteral formulation of an antileishmanial drug candidate – Tackling poor solubility, chemical instability, and polymorphism

(2013) Eva Kupetz et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo

(2013) Pinaki R. Desai et al.   JOURNAL OF CONTROLLED RELEASE

Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting

(2012) Joy Wan   ARCHIVES OF DERMATOLOGY

Enhanced skin permeation using polyarginine modified nanostructured lipid carriers

(2012) Punit P. Shah et al.   JOURNAL OF CONTROLLED RELEASE

Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review

(2012) E. Archier et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Advances in the treatment of moderate-to-severe plaque psoriasis

(2011) R. N. Herrier   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs

(2011) Punit P. Shah et al.   BIOMATERIALS

CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis

(2011) Ivan V. Litvinov et al.   EXPERIMENTAL DERMATOLOGY

Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model

(2011) Kimiko Nakajima et al.   JOURNAL OF IMMUNOLOGY

Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Combined with Functional Peptides Tat and AT1002

(2011) T. Uchida et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The therapeutic potential of TNF-α antagonists for skin psoriasis comorbidities

(2010) Gérald E Piérard et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1 , and TNF-  Recapitulates Some Features of Psoriasis

(2010) K. Guilloteau et al.   JOURNAL OF IMMUNOLOGY

Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

(2010) Batya B. Davidovici et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery

(2010) Pinaki Desai et al.   MOLECULAR MEMBRANE BIOLOGY

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

(2010) Christopher E.M. Griffiths et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis

(2010) Pieter C. M. Res et al.   PLoS One

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

(2010) W. Hueber et al.   Science Translational Medicine

Comorbidities in Psoriasis Patients

(2010) Noori Kim et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Lipid-based systemic delivery of siRNA

(2009) Yu-Cheng Tseng et al.   ADVANCED DRUG DELIVERY REVIEWS

Delivery of RNA interference therapeutics using polycation-based nanoparticles

(2009) Kenneth Alan Howard   ADVANCED DRUG DELIVERY REVIEWS

Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies

(2009) Luigi Naldi   CLINICS IN DERMATOLOGY

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

(2009) N. N. Mehta et al.   EUROPEAN HEART JOURNAL

Enhancement of Topical Small Interfering RNA Delivery and Expression by Low-Fluence Erbium:YAG Laser Pretreatment of Skin

(2009) Woan-Ruoh Lee et al.   HUMAN GENE THERAPY

Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat

(2009) K. Kigasawa et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Thixotropic property in pharmaceutical formulations

(2009) Chi H. Lee et al.   JOURNAL OF CONTROLLED RELEASE

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

(2009) L. van der Fits et al.   JOURNAL OF IMMUNOLOGY

IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not

(2009) Kerstin Wolk et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Treatments for psoriasis and the risk of malignancy

(2009) Rita V. Patel et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Eventration caused by methotrexate in a psoriatic patient

(2009) H Conte et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Economic evaluation of systemic therapies for moderate to severe psoriasis

(2008) S. Sizto et al.   BRITISH JOURNAL OF DERMATOLOGY

Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model

(2008) Kenneth A Howard et al.   MOLECULAR THERAPY

Skin Irritation and Sensitization: Mechanisms and New Approaches for Risk Assessment

(2008) J.W. Fluhr et al.   SKIN PHARMACOLOGY AND PHYSIOLOGY

Formulation and Evaluation of Flurbiprofen Microemulsion

(2008) K. Jadhav et al.   Current Drug Delivery

Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases

(2007) Shigetoshi Sano et al.   JOURNAL OF DERMATOLOGICAL SCIENCE